Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BMYMP - Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2022 Results - Earnings Call Transcript

BMYMP - Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2022 Results - Earnings Call Transcript

Bristol-Myers Squibb $2Pr
Bristol-Myers Squibb Company (BMY) Q1 2022 Results Conference Call April 29, 2022 08:00 AM ET Company Participants Tim Power - VP & Head, IR Giovanni Caforio - Board Chair & CEO David Elkins - CFO Chris Boerner - Chief Commercialization Officer Samit Hirawat - Chief Medical Officer and Head of Global Drug Development Conference Call Participants Chris Schott - JPMorgan Chris Shibutani - Goldman Sachs Geoff Meacham - Bank of America Seamus Fernandez - Guggenheim Evan Seigerman - BMO Andrew Baum - Citi Steve Scala - Cowen Luisa Hector - Berenberg Terence Flynn - Morgan Stanley Dane Leone - Raymond James Presentation Operator Good day, and welcome to the Bristol-Myers Squibb 2022 First Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir. Tim Power Thank you, Sergei,

For further details see:

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Bristol-Myers Squibb $2Pr
Stock Symbol: BMYMP
Market: OTC
Website: bms.com
Menu
BMYMP BMYMP Quote BMYMP Short BMYMP News BMYMP Articles BMYMP Message Board
Get BMYMP Alerts

News, Short Squeeze, Breakout and More Instantly...